SPARC and colorectal carcinoma: Furthermore, stattic reversed the effects of SPARC overexpression on 5‐FU resistance in CRC cells, as evidenced by the colony formation, CCK‐8, and flow cytometry‐based apoptosis assays (Figure 5C–E).